Yanhong Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yanhong Hou has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Claus Cursiefen
Department of Ophthalmology, University of Cologne Faculty of Medicine and University Hospital Cologne Koln Germany
3 shared publications- Felix Bock
Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
3 shared publications - Claus Cursiefen
Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany
2 shared publications - Jin Yang
Department of Ophthalmology, Eye, Ear, Nose, and Throat Hospital of Fudan University, Shanghai, People’s Republic of China
2 shared publications Shuya Deng
Department of Ophthalmology, University of Cologne Faculty of Medicine and University Hospital Cologne Koln Germany
2 shared publications- Viet Nhat Hung Le
Department of Ophthalmology, University of Cologne Faculty of Medicine and University Hospital Cologne Koln Germany
2 shared publications
Latest Publications
- 15 July 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
Rotational Stability of Three Toric Intraocular Lens Platforms After Cataract Surgery: A Prospective Multicenter Randomized Trial
Purpose: To compare the postoperative rotational stability of three toric intraocular lens (IOL) platforms and identify platform-specific biometric factors associated with rotation. Setting: Three eye centers in China. Design: Prospective multicenter randomized controlled trial. Methods: A total of 256 eyes of 172 cataract patients with regular corneal astigmatism that completed 3 months of follow-up after phacoemulsification with implantation of TECNIS Toric II, Clareon Toric, or AT TORBI 709M were included. Participants were randomly assigned to 1 of the 3 toric IOL platforms. Baseline rotational alignment was defined at the end of surgery and compared with retroillumination images obtained at 1 day, 3 days, 1 week, 2 weeks, 1 month, and 3 months postoperatively. Results: Absolute rotation changed most prominently within the first week and then progressively stabilized. Rotational stability was reached earlier in the ZCU and CNW0T groups, which plateaued at 1 week, whereas the 709 approached stability between 2 weeks and 1 month. Throughout follow-up, the 709 showed greater rotation than the CNW0T, whereas the ZCU demonstrated the least rotation. Significant rotation of ≥10° occurred in 1.2%, 2.4%, and 12.2% of eyes, respectively. White-to-white distance was associated with greater rotation in the CNW0T and 709 groups, lens thickness was additionally associated with greater rotation in the 709 group, and no biometric factor reached significance in the ZCU group. Conclusions: Hydrophobic C-loop toric IOLs showed better early rotational stability than the hydrophilic plate-haptic toric IOL. Biometric correlates of rotation differed across platforms, supporting individualized toric IOL selection and postoperative monitoring.
- 15 July 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
Rotational Stability of Three Toric Intraocular Lens Platforms After Cataract Surgery: A Prospective Multicenter Randomized Trial
Purpose: To compare the postoperative rotational stability of three toric intraocular lens (IOL) platforms and identify platform-specific biometric factors associated with rotation. Setting: Three eye centers in China. Design: Prospective multicenter randomized controlled trial. Methods: A total of 256 eyes of 172 cataract patients with regular corneal astigmatism that completed 3 months of follow-up after phacoemulsification with implantation of TECNIS Toric II, Clareon Toric, or AT TORBI 709M were included. Participants were randomly assigned to 1 of the 3 toric IOL platforms. Baseline rotational alignment was defined at the end of surgery and compared with retroillumination images obtained at 1 day, 3 days, 1 week, 2 weeks, 1 month, and 3 months postoperatively. Results: Absolute rotation changed most prominently within the first week and then progressively stabilized. Rotational stability was reached earlier in the ZCU and CNW0T groups, which plateaued at 1 week, whereas the 709 approached stability between 2 weeks and 1 month. Throughout follow-up, the 709 showed greater rotation than the CNW0T, whereas the ZCU demonstrated the least rotation. Significant rotation of ≥10° occurred in 1.2%, 2.4%, and 12.2% of eyes, respectively. White-to-white distance was associated with greater rotation in the CNW0T and 709 groups, lens thickness was additionally associated with greater rotation in the 709 group, and no biometric factor reached significance in the ZCU group. Conclusions: Hydrophobic C-loop toric IOLs showed better early rotational stability than the hydrophilic plate-haptic toric IOL. Biometric correlates of rotation differed across platforms, supporting individualized toric IOL selection and postoperative monitoring.
- Open Access
- 4 February 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 285, 152-160
Three-Year Outcomes of Toric vs Nontoric Monofocal Intraocular Lens Implantation in Children Aged 3–8 Years With Congenital Cataract
- 4 February 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 285, 152-160
Open AccessThree-Year Outcomes of Toric vs Nontoric Monofocal Intraocular Lens Implantation in Children Aged 3–8 Years With Congenital Cataract
- Open Access
- 30 April 2024
- Published by Wiley in Acta Ophthalmologica
- Vol. 102 (7) , e1002-e1010
Efficacy and safety of combined UV‐light corneal crosslinking and fine‐needle diathermy to regress pathological murine corneal (lymph)angiogenesis in vivo
Purpose: To compare safety and efficacy of isolated and combined UV‐light corneal crosslinking (CXL) and fine‐needle diathermy (FND) to regress pathological corneal vessels in vivo.Methods: Mice with inflamed and pathologically vascularized corneas received CXL or FND as monotherapy or a combination of both treatments. Corneal pathological blood and lymphatic vessels, immune cells and the morphology of anterior segment structures were evaluated.Results: All three approaches were able to regress blood and lymphatic vessels in mice. A comparative analysis of the three methods revealed that the FND monotherapy and the CXL + FND combination were significantly more effective than the CXL monotherapy, one and 2 weeks after therapy and especially in regressing lymphatic vessels. Furthermore, the combination therapy induced significantly less immune cell recruitment compared to the monotherapies. All three methods were safe to use in regards of corneal integrity.Conclusions: A combination of FND and CXL led to regression of pathological corneal lymphatic and blood vessels and reduced the infiltration of immune cells into inflamed murine corneas. This approach offers a new effective, safe and clinically usable strategy to treat eyes with mature pathological blood vessels and even more so for lymphatic vessels, for example prior to high‐risk corneal transplantation.
- 30 April 2024
- Published by Wiley in Acta Ophthalmologica
- Vol. 102 (7) , e1002-e1010
Open AccessEfficacy and safety of combined UV‐light corneal crosslinking and fine‐needle diathermy to regress pathological murine corneal (lymph)angiogenesis in vivo
Purpose: To compare safety and efficacy of isolated and combined UV‐light corneal crosslinking (CXL) and fine‐needle diathermy (FND) to regress pathological corneal vessels in vivo.Methods: Mice with inflamed and pathologically vascularized corneas received CXL or FND as monotherapy or a combination of both treatments. Corneal pathological blood and lymphatic vessels, immune cells and the morphology of anterior segment structures were evaluated.Results: All three approaches were able to regress blood and lymphatic vessels in mice. A comparative analysis of the three methods revealed that the FND monotherapy and the CXL + FND combination were significantly more effective than the CXL monotherapy, one and 2 weeks after therapy and especially in regressing lymphatic vessels. Furthermore, the combination therapy induced significantly less immune cell recruitment compared to the monotherapies. All three methods were safe to use in regards of corneal integrity.Conclusions: A combination of FND and CXL led to regression of pathological corneal lymphatic and blood vessels and reduced the infiltration of immune cells into inflamed murine corneas. This approach offers a new effective, safe and clinically usable strategy to treat eyes with mature pathological blood vessels and even more so for lymphatic vessels, for example prior to high‐risk corneal transplantation.
- 31 May 2023
- Published by Wiley in Acta Ophthalmologica
- Vol. 102 (1) , e134-e137
Corneal crosslinking ameliorates the extent of corneal oedema in subsequent acute keratoconus in an ex vivo model
- 31 May 2023
- Published by Wiley in Acta Ophthalmologica
- Vol. 102 (1) , e134-e137
Corneal crosslinking ameliorates the extent of corneal oedema in subsequent acute keratoconus in an ex vivo model
- Open Access
Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival
(Lymph)angiogenesis into the cornea prior to and after corneal transplantation is a critical risk factor for allograft rejection. Lymphatic vessels even more than blood vessels seem important in mediating immune responses, as they facilitate allograft sensitization in the draining lymph nodes. Thus, the concept of modulating lymphatic trafficking to promote corneal graft survival seems promising. A variety of approaches has been developed to inhibit progressive lymphangiogenesis in experimental settings. Recently, additionally to pharmacological approaches, clinically available techniques such as UVA-based corneal collagen crosslinking and fine needle diathermy were reported to be effective in regressing lymphatic vessels and to experimentally promote graft survival. Clinical pilot studies also suggest the efficacy of blocking antigen presenting cell trafficking to regional lymph nodes by regressing corneal lymphatic vessels to enhance allograft survival in high-risk eyes. In this article, we will give an overview of current strategies to modulate lymphatic trafficking with a special focus on recently reported strategies, which may be easy to translate into clinical practice. This novel concept of temporary, pretransplant regression of lymphatic vessels at the site of transplantation to promote subsequent corneal transplant survival (“lymphangioregressive preconditioning”) may also be applicable to other transplantation sites later.
Open AccessLymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival
(Lymph)angiogenesis into the cornea prior to and after corneal transplantation is a critical risk factor for allograft rejection. Lymphatic vessels even more than blood vessels seem important in mediating immune responses, as they facilitate allograft sensitization in the draining lymph nodes. Thus, the concept of modulating lymphatic trafficking to promote corneal graft survival seems promising. A variety of approaches has been developed to inhibit progressive lymphangiogenesis in experimental settings. Recently, additionally to pharmacological approaches, clinically available techniques such as UVA-based corneal collagen crosslinking and fine needle diathermy were reported to be effective in regressing lymphatic vessels and to experimentally promote graft survival. Clinical pilot studies also suggest the efficacy of blocking antigen presenting cell trafficking to regional lymph nodes by regressing corneal lymphatic vessels to enhance allograft survival in high-risk eyes. In this article, we will give an overview of current strategies to modulate lymphatic trafficking with a special focus on recently reported strategies, which may be easy to translate into clinical practice. This novel concept of temporary, pretransplant regression of lymphatic vessels at the site of transplantation to promote subsequent corneal transplant survival (“lymphangioregressive preconditioning”) may also be applicable to other transplantation sites later.
- Open Access
- 14 January 2021
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 394 (6) , 1315-1319
A teaching tool about the fickle p value and other statistical principles based on real-life data
A poor understanding of statistical analysis has been proposed as a key reason for lack of replicability of many studies in experimental biomedicine. While several authors have demonstrated the fickleness of calculated p values based on simulations, we have experienced that such simulations are difficult to understand for many biomedical scientists and often do not lead to a sound understanding of the role of variability between random samples in statistical analysis. Therefore, we as trainees and trainers in a course of statistics for biomedical scientists have used real data from a large published study to develop a tool that allows scientists to directly experience the fickleness of p values. A tool based on a commonly used software package was developed that allows using random samples from real data. The tool is described and together with the underlying database is made available. The tool has been tested successfully in multiple other groups of biomedical scientists. It can also let trainees experience the impact of randomness, sample sizes and choice of specific statistical test on measured p values. We propose that live exercises based on real data will be more impactful in the training of biomedical scientists on statistical concepts.
- 14 January 2021
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 394 (6) , 1315-1319
Open AccessA teaching tool about the fickle p value and other statistical principles based on real-life data
A poor understanding of statistical analysis has been proposed as a key reason for lack of replicability of many studies in experimental biomedicine. While several authors have demonstrated the fickleness of calculated p values based on simulations, we have experienced that such simulations are difficult to understand for many biomedical scientists and often do not lead to a sound understanding of the role of variability between random samples in statistical analysis. Therefore, we as trainees and trainers in a course of statistics for biomedical scientists have used real data from a large published study to develop a tool that allows scientists to directly experience the fickleness of p values. A tool based on a commonly used software package was developed that allows using random samples from real data. The tool is described and together with the underlying database is made available. The tool has been tested successfully in multiple other groups of biomedical scientists. It can also let trainees experience the impact of randomness, sample sizes and choice of specific statistical test on measured p values. We propose that live exercises based on real data will be more impactful in the training of biomedical scientists on statistical concepts.
- Open Access
- 3 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Supplemental Anti Vegf A-Therapy Prevents Rebound Neovascularisation After Fine Needle Diathermy Treatment to Regress Pathological Corneal (LYMPH)Angiogenesis
Fine needle diathermy (FND) is an effective method to destroy and regress pathologic corneal blood and lymphatic vessels. However, it is unknown whether FND itself causes a rebound corneal neovascularisation and whether that can be prevented by VEGF blockade. In female BALB/c mice, the suture-induced inflammatory corneal neovascularisation model was used to induce hem- and lymphangiogenesis. Thereafter, prevascularized mice were divided into 2 groups: the combination therapy group received FND cauterization and subsequent VEGF TrapR1R2 eye drops three times per day whereas the monotherapy group was treated only with FND. Three, 7 and 14 days after the treatment, corneas were collected and stained with FITC-conjugated CD31 and LYVE-1 followed by Cy3-conjugated secondary antibody to quantify corneal blood and lymphatic vessels. Relative mRNA expression of VEGF in the cornea was quantified by using qPCR. FND cauterization as monotherapy significantly obliterated (lymph)angiogenesis at early time points; however, this treatment led to secondary corneal hem- and lymphangiogenesis associated with significant upregulation of pro(lymph)angiogenic VEGF-A, VEGF-C, VEGF-D and infiltration of macrophages. Combining FND cauterization with VEGF TrapR1R2 treatment prevented the undesired effect of the FND procedure alone and significantly better regressed corneal blood and lymphatic vessels at 1 week after the treatment compared to monotherapy and control group (p < 0.01).
- 3 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Open AccessSupplemental Anti Vegf A-Therapy Prevents Rebound Neovascularisation After Fine Needle Diathermy Treatment to Regress Pathological Corneal (LYMPH)Angiogenesis
Fine needle diathermy (FND) is an effective method to destroy and regress pathologic corneal blood and lymphatic vessels. However, it is unknown whether FND itself causes a rebound corneal neovascularisation and whether that can be prevented by VEGF blockade. In female BALB/c mice, the suture-induced inflammatory corneal neovascularisation model was used to induce hem- and lymphangiogenesis. Thereafter, prevascularized mice were divided into 2 groups: the combination therapy group received FND cauterization and subsequent VEGF TrapR1R2 eye drops three times per day whereas the monotherapy group was treated only with FND. Three, 7 and 14 days after the treatment, corneas were collected and stained with FITC-conjugated CD31 and LYVE-1 followed by Cy3-conjugated secondary antibody to quantify corneal blood and lymphatic vessels. Relative mRNA expression of VEGF in the cornea was quantified by using qPCR. FND cauterization as monotherapy significantly obliterated (lymph)angiogenesis at early time points; however, this treatment led to secondary corneal hem- and lymphangiogenesis associated with significant upregulation of pro(lymph)angiogenic VEGF-A, VEGF-C, VEGF-D and infiltration of macrophages. Combining FND cauterization with VEGF TrapR1R2 treatment prevented the undesired effect of the FND procedure alone and significantly better regressed corneal blood and lymphatic vessels at 1 week after the treatment compared to monotherapy and control group (p < 0.01).
- Open Access
- 19 April 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (12) , 2873-2884
UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival
- 19 April 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (12) , 2873-2884
Open AccessUV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival